GLP-1 meds linked to lower diabetes, heart risks than standard diabetes prevention med

Coverage, in order

1. 9d ago
   
   first AHA Newsroom indie study observationaln=250,000

   GLP-1 meds linked to lower diabetes, heart risks than standard diabetes prevention med

   Research Highlights: Among more than 250,000 adults with prediabetes and obesity, those taking glucagon-like peptide-1 receptor agonists (GLP-1 medications) were about 1.5 times more likely to reverse blood sugar to normal levels compared to those taking the standard Type 2 diabetes prevention…

2. 9d ago
   
   Medical Xpress indie study observational

   GLP-1 meds linked to lower diabetes, heart risks than standard diabetes prevention medication

   GLP-1 (glucagon-like peptide-1 receptor agonists) medications, currently popular for weight loss, may help prevent type 2 diabetes and lower the risk of heart attack and stroke more than the standard diabetes prevention medication metformin among people with prediabetes, according to new…

3. 8d ago
   
   Healthline mainstream

   GLP-1s May Help Lower Diabetes, Heart Risks Better Than Standard Prevention

   GLP-1 drugs like Ozempic and Mounjaro treated prediabetes more effectively than metformin, according to a new study. Milko/E+/Getty Images Researchers say GLP-1 medications appear to be more effective in treating prediabetes than the commonly prescribed drug metformin. They said GLP-1 drugs were…

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.